LAVSX
Price
$15.88
Change
+$0.09 (+0.57%)
Updated
Jan 23 closing price
Net Assets
2.01B
RMEBX
Price
$57.15
Change
+$0.51 (+0.90%)
Updated
Jan 23 closing price
Net Assets
104.41B
Ad is loading...

LAVSX vs RMEBX

Header iconLAVSX vs RMEBX Comparison
Open Charts LAVSX vs RMEBXBanner chart's image
Lord Abbett Fundamental Equity R4
Price$15.88
Change+$0.09 (+0.57%)
VolumeN/A
Net Assets2.01B
American Funds American Mutual R2E
Price$57.15
Change+$0.51 (+0.90%)
VolumeN/A
Net Assets104.41B
LAVSX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAVSX vs. RMEBX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVSX is a Hold and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 104B vs. LAVSX (2.01B). RMEBX pays higher dividends than LAVSX: RMEBX (1.54) vs LAVSX (0.74). LAVSX was incepted earlier than RMEBX: LAVSX (10 years) vs RMEBX (10 years). LAVSX (26.00) and RMEBX (25.00) have comparable annual turnover. LAVSX has a lower initial minimum investment than RMEBX: LAVSX (0) vs RMEBX (250). LAVSX annual gain was more profitable for investors over the last year : 20.57 vs. RMEBX (13.63). RMEBX return over 5 years is better than : 40.60 vs. LAVSX (37.11).
LAVSXRMEBXLAVSX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years10 years-
Gain YTD6.1504.098150%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.01B104B2%
Annual Yield % from dividends0.741.5448%
Returns for 1 year20.5713.63151%
Returns for 3 years22.9316.79137%
Returns for 5 years37.1140.6091%
Returns for 10 yearsN/A64.97-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSLR174.112.21
+1.29%
First Solar
AAMI25.660.26
+1.02%
Acadian Asset Management Inc
SHC13.690.09
+0.66%
Sotera Health Company
VERI3.15-0.03
-0.94%
Veritone
ACXP0.83-0.02
-2.36%
Acurx Pharmaceuticals